Publications by authors named "Jennifer Barks"

Claim this Profile
O
Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis.
James W Janetka, Allen T Hopper, Ziping Yang, Jennifer Barks, Mary Savari Dhason

J Med Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.
Allen T Hopper, Adam Brockman, Andy Wise, Julie Gould, Jennifer Barks

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression .
Georgia Wilke, Soumya Ravindran, Lisa Funkhouser-Jones, Jennifer Barks, Qiuling Wang

mSphere· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
Florentine U Rutaganira, Jennifer Barks, Mary Savari Dhason, Qiuling Wang, Michael S Lopez

J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.
Sebastian Lourido, Chao Zhang, Michael S Lopez, Keliang Tang, Jennifer Barks

J Med Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1.
Leonidas N Carayannopoulos, Jennifer L Barks, Wayne M Yokoyama, Joan K Riley

Biol Reprod· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis.
Debra M Meyer, Michael I Jesson, Xiong Li, Mollisa M Elrick, Christie L Funckes-Shippy, Jennifer L Barks

J Inflamm (Lond)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis